Physician profile
Nikhil Narang
NPI 1922362383
$114,344.47
in general payments reported to CMS, 2019-2025
28 companies · $16K in 2025
The $16K reported for 2025 was more than what 96% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,792 · 2020: $3,349 · 2021: $16K · 2022: $23K · 2023: $32K · 2024: $18K · 2025: $16K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $52K · Food and Beverage: $6,058 · Honoraria: $5,500 · Travel and Lodging: $1,690 · Consulting Fee: $1,410.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $51,710.00 |
| Food and Beverage | $6,058.20 |
| Honoraria | $5,500.00 |
| Travel and Lodging | $1,690.02 |
| Consulting Fee | $1,410.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $42,105.60 | 2021-2025 | Jardiance |
| Abbott Laboratories | $26,985.01 | 2019-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems, Freestyle Libre |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $19,654.23 | 2019-2024 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $7,714.86 | 2019-2025 | Wainua, Lokelma |
| Alnylam Pharmaceuticals INC. | $4,756.47 | 2021-2023 | Amvuttra |
| Lilly USA, LLC | $4,680.00 | 2023-2025 | Jardiance |
| Amgen INC. | $2,551.44 | 2020-2021 | |
| Akcea Therapeutics, INC. | $2,216.04 | 2019 | |
| Zoll Circulation INC | $1,350.00 | 2025 | Therox Ds2 Console, Catheter, Downstream Cartridge |
| Abiomed | $566.01 | 2021-2023 | Impella |
| Medtronic Vascular, INC. | $376.13 | 2019-2020 | |
| Novo Nordisk INC | $346.48 | 2021-2024 | Ozempic |
| Cvrx, INC. | $330.64 | 2023-2024 | Barostim Neo System |
| Pfizer INC. | $167.04 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $118.41 | 2023-2024 | Camzyos |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $58.90 | 2021-2024 | |
| Janssen Pharmaceuticals, INC | $49.62 | 2019-2022 | |
| United Therapeutics Corporation | $46.14 | 2019 | |
| Lexicon Pharmaceuticals, INC. | $45.64 | 2023-2024 | Inpefa |
| Bridgebio Pharma, INC. | $45.34 | 2025 | Attruby |
| Medtronic, INC. | $38.09 | 2021-2023 | Hvad Pump Implant Kit |
| Daxor Corporation | $33.92 | 2025 | Bva-100 |
| Endotronix, INC. | $23.16 | 2025 | Cordella Pulomonary Artery Pressure Sensor |
| Scpharmaceuticals INC. | $21.63 | 2025 | |
| Lantheus Medical Imaging, INC. | $17.31 | 2019 | |
| Janssen Scientific Affairs, LLC | $17.00 | 2020 | |
| Terumo Medical Corporation | $16.53 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $12.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nikhil Narang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.